BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25194444)

  • 1. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
    Izgi A; Gunal A; Yalcin S; Gunduz U
    Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human POT1 facilitates telomere elongation by telomerase.
    Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR
    Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.
    Zaug AJ; Podell ER; Cech TR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10864-9. PubMed ID: 16043710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
    Gao J; Zhang J; Long Y; Lu X
    Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
    Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
    Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.
    Armbruster BN; Linardic CM; Veldman T; Bansal NP; Downie DL; Counter CM
    Mol Cell Biol; 2004 Apr; 24(8):3552-61. PubMed ID: 15060173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S; Shiota G; Kawasaki H
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching human telomerase on and off with hPOT1 protein in vitro.
    Lei M; Zaug AJ; Podell ER; Cech TR
    J Biol Chem; 2005 May; 280(21):20449-56. PubMed ID: 15792951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics.
    Possemato R; Timmons JC; Bauerlein EL; Wada N; Baldwin A; Masutomi K; Hahn WC
    Mol Cancer Res; 2008 Oct; 6(10):1582-93. PubMed ID: 18922974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of hPot1 function leads to telomere instability and a cut-like phenotype.
    Veldman T; Etheridge KT; Counter CM
    Curr Biol; 2004 Dec; 14(24):2264-70. PubMed ID: 15620654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression.
    Wan SM; Tie J; Zhang YF; Guo J; Yang LQ; Wang J; Xia SH; Yang SM; Wang RQ; Fang DC
    J Clin Pathol; 2011 Dec; 64(12):1051-7. PubMed ID: 21778296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere neurobiology.
    Mattson MP; Zhang P; Cheng A
    Methods Mol Biol; 2008; 438():185-96. PubMed ID: 18369758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two faces of Solanaceae telomeres: a comparison between Nicotiana and Cestrum telomeres and telomere-binding proteins.
    Peska V; Sýkorová E; Fajkus J
    Cytogenet Genome Res; 2008; 122(3-4):380-7. PubMed ID: 19188709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.